FilingReader Intelligence
Laobaixing Pharmacy Chain reports 21% profit drop
August 25, 2025 at 08:21 AM UTC•By FilingReader AI
Laobaixing Pharmacy Chain reported operating revenue of 10.8 billion yuan for H1 2025, down 1.51% year-on-year. Net profit attributable to shareholders fell 20.86% to 398 million yuan.
The company will repurchase and cancel 1.2 million restricted shares at 11.605 yuan per share following a dividend distribution.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Special report on the deposit and use of raised funds for the first half of 2025August 25, 2025 at 08:00 AM UTC
2025 semi-annual reportAugust 25, 2025 at 08:00 AM UTC
2025 semi-annual report summaryAugust 25, 2025 at 08:00 AM UTC
Legal opinion on the repurchase and cancellation of remaining restricted shares and the adjustment of the repurchase price for the 2022 restricted stock incentive plan of Laobaixing Pharmacy Chain Co., Ltd. by Hunan Qiyuan Law FirmAugust 25, 2025 at 08:00 AM UTC
Announcement on adjusting the repurchase price of the 2022 restricted stock incentive planAugust 25, 2025 at 08:00 AM UTC
Announcement to creditors regarding the repurchase and cancellation of restricted sharesAugust 25, 2025 at 08:00 AM UTC
SSE:603883•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Laobaixing Pharmacy Chain JSC publishes news
Free account required • Unsubscribe anytime